Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 1331-1340 of 13504

Page
per page
  1. BRD3308
    A4611 BRD3308
      ≥8.85 mg/mL
  2. Acetamide
    C6269 Acetamide
    Summary: An organic intermediate used for the synthesis of methylamine, insecticides, and plasticizers.
      ≥38.6 mg/mL
  3. Quisinostat dihydrochloride
    A4610 Quisinostat dihydrochloride
      ≥52.6 mg/mL
  4. Pibrentasvir
    BA1851 Pibrentasvir
    Summary: Pibrentasvir is a novel pan-genotypic hepatitis C virus inhibitor.
      ≥25.5 mg/mL
  5. (3,4-Dimethoxyphenyl)acetic acid
    C6240 (3,4-Dimethoxyphenyl)acetic acid
    Summary: A synthetic intermediate and structural building block for drug synthesis featuring a methoxy aromatic structure.
  6. TBHQ
    A4790 TBHQ
      ≥22.3 mg/mL
  7. Lagociclovir
    BA1850 Lagociclovir
    Summary: Lagociclovir (FLG) is a nucleoside analog.
  8. Isonicotinic acid
    C6135 Isonicotinic acid
    Summary: A metabolite used for research on isoniazid metabolism and related enzyme activity.
      insoluble in EtOH; insoluble in H2O; ≥9.55 mg/mL
  9. Curcumin
    A3335 Curcumin
     1 Citation
    Target: Histone Deacetylases (HDACs)|Nrf2|Histone Acetyltransferases (HATs)|Tyrosinases
    Summary: Specific histone and non-histone acetyltransferase inhibitor
      ≥36.8 mg/mL
  10. HBV-IN-37
    BA1849 HBV-IN-37
    Summary: HBV-IN-37 is an inhibitor.

Items 1331-1340 of 13504

Page
per page